Feedback PLC First server sale of TexRAD in Canada (9742P)
12 Juni 2015 - 8:00AM
UK Regulatory
TIDMFDBK
RNS Number : 9742P
Feedback PLC
12 June 2015
12 June 2015
Feedback plc
("Feedback" or the "Group")
First server sale of TexRAD in Canada
Feedback plc (AIM: FDBK), the medical imaging software company,
is pleased to announce its first server sale for research purposes
in Canada of the Group's TexRAD texture analysis software. The
software will be installed in the Department of Diagnostic
Radiology at the McGill University Health Centre's ("MUHC")
Montreal General Hospital site.
The MUHC is one of the leading academic health centres in North
America. It was founded in 1997 through the merger of five
hospitals including the Montreal General Hospital which was
established in 1819 and was one of the world's first teaching
hospitals.
Professor Benoit Gallix, Chairman, Department of Diagnostic
Radiology (McGill University Director, MUHC) commented, "We are
very excited with the prospect of evaluating the TexRAD imaging
research software platform at our institution as a potential
imaging risk-stratification tool. TexRAD will form part of a
research study of breast cancer patients who have had digital
mammography imaging examinations. The MUHC database has
approximately 20,000 digital mammograms with clinical follow-up
acquired over a period of 15 to 20 years. This comprehensive
research study could help to provide an evidence base for the
potential application of TexRAD in breast cancer patient
management"
Dr. Balaji Ganeshan, Chief Scientist and New Business Officer at
the Group's subsidiaries TexRAD Ltd and Cambridge Computed Imaging
Ltd, commented, "We are delighted to receive this first server
order in Canada, particularly from the very prestigious MUHC,
Montreal, Quebec and we are honoured to be working with Professor
Benoit Gallix and his team. Breast cancer is the most common cancer
in the UK with around 55,000 people (predominantly women) diagnosed
with the disease every year. Research and development into
non-invasive imaging based risk-stratification tools such as TexRAD
research software could potentially lead to TexRAD's use as a
supplementary tool in digital mammography to achieve better patient
management and improved overall outcomes in the future."
For further information contact:
Feedback plc Tel: 01954
718072
Simon Barrell / Trevor Brown
/ Tom Charlton
Sanlam Securities UK (Nominated Adviser and
Joint Broker)
Simon Clements / Virginia Bull Tel: 020 7628
2200
Peterhouse Corporate Finance Tel: 020 7469
Ltd (Joint Broker) 0936
Lucy Williams / Duncan Vasey
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCEAKKFFAESEFF
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Feedback (LSE:FDBK)
Historical Stock Chart
Von Jul 2023 bis Jul 2024